fda to reconsider tirzepatide confirms shortage is still over, gives compounders a grace period What is the latest update

People new to GLP-1 agonists If retatrutide is your first exposure to any GLP-1 receptor agonist, start at the lowest practical dose

Both peptides significantly increase IGF-1 (80-100 percent for Tesamorelin, similar for CJC-1295 DAC), but with radically different kinetics: daily injection for Tesamorelin vs weekly for CJC-1295 DAC

If needed, we can add IV therapy for nutrient repletion, body contouring for stubborn areas, or hormone optimization to address underlying imbalances

These injections have gained popularity as a method to enhance skin beauty due to their skin-brightening and antioxidant properties